Key takeaways
Triumeq (abacavir/dolutegravir/lamivudine) and Truvada (emtricitabine/tenofovir disoproxil fumarate) are both used to treat HIV, but they have some key differences. Triumeq is a single-tablet regimen that combines three medications, while Truvada combines two medications and must be taken with another HIV medication for complete treatment. Triumeq requires a genetic test before starting to check for a risk of serious allergic reactions, whereas Truvada does not. Truvada is also approved for HIV PrEP (pre-exposure prophylaxis) to prevent HIV infection, while Triumeq is not. Triumeq can cause serious liver problems and requires careful monitoring, especially if you have hepatitis B, while Truvada is more likely to cause bone problems and kidney issues. Additionally, Truvada is available as a lower-cost generic, making it more accessible. Both medications are taken once daily and require regular blood tests to monitor for side effects and effectiveness.
